EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Diagnostics for priority bacterial pathogens: global gaps and research needs for curbing antimicrobial resistance in low-resource settings

Valeria Gigante, Maurine Murtagh, Till T Bachmann, Tamarie Rocke, Betsy W Trainor, Susan M Poutanen, Teri Roberts, Jordi Vila, Alexandra Cameron

The Lancet Microbe · 2026-07 · 7 (7) · 101385

DOI: 10.1016/j.lanmic.2026.101385 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Lancet Microbe, 2026-07. Verfasst von Valeria Gigante und 8 weiteren Autor:innen. Beteiligte Einrichtung: AMR Department, WHO, Geneva, Switzerland. Electronic address: gigantev@who.int. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial, Bacteria, Bacterial Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: World Health Organization, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) is a major and growing threat to global health, development, and security, with the greatest burden borne by low-income and middle-income countries (LMICs). Without urgent intervention, cumulative deaths between 2020 and 2050, attributable to AMR, are projected to be 39·1 million globally. Effective diagnostics are important to bacterial pathogen detection and antimicrobial susceptibility testing, and such diagnostics support antibiotic stewardship by reducing adverse drug events (eg, toxicity or allergy) and restricting the emergence and spread of AMR. Yet, access to appropriate diagnostics in LMICs remains constrained. This Review summarises the current landscape of commercial and pipeline bacterial in-vitro diagnostics, drawing on the updated WHO 2024 Bacterial Priority Pathogen List, the 2025 WHO diagnostic landscape analysis, and the WHO Diagnostic Initiative, which has four pillars, one of which focuses on research and innovation to improve diagnostics for AMR. We discuss phenotypic and non-phenotypic testing approaches, assess platform suitability across health system tiers in LMICs, and outline WHO priorities for the next 3-5 years to guide innovation and improve equitable access. Although multiple commercial platforms exist for bacterial identification and susceptibility or resistance testing, most platforms are infrastructure-intensive and confined to regional or reference laboratories, leaving major diagnostic gaps at primary and secondary care levels. Promising advances include rapid immunoassays and emerging molecular platforms; however, no simple, affordable, decentralised solution provides reliable identification and susceptibility or resistance testing for key bacterial priority pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, BacterialBacteriaBacterial InfectionsHumansResource-Limited SettingsAnti-Bacterial AgentsDeveloping CountriesMicrobial Sensitivity TestsGlobal HealthAntimicrobial Stewardship

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • AMR Department, WHO, Geneva, Switzerland. Electronic address: gigantev@who.int.
  • AMR Department, WHO, Geneva, Switzerland; The Murtagh Group, Woodside, CA, USA.
  • Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.
  • AMR Department, WHO, Geneva, Switzerland.
  • Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), Boston, MA, USA.
  • Sinai Health, University Health Network, University of Toronto, Toronto, ON, Canada.

Förderung

  • World Health Organization
  • European Commission

Zitieren

APA

Gigante, V., Murtagh, M., Bachmann, T. T., Rocke, T., Trainor, B. W., Poutanen, S. M., Roberts, T., Vila, J., & Cameron, A. (2026). Diagnostics for priority bacterial pathogens: global gaps and research needs for curbing antimicrobial resistance in low-resource settings. The Lancet Microbe, 7(7), 101385. https://doi.org/10.1016/j.lanmic.2026.101385

Vancouver

Gigante V, Murtagh M, Bachmann TT, Rocke T, Trainor BW, Poutanen SM, et al. Diagnostics for priority bacterial pathogens: global gaps and research needs for curbing antimicrobial resistance in low-resource settings. The Lancet Microbe. 2026;7(7):101385. doi:10.1016/j.lanmic.2026.101385

BibTeX
@article{Gigante2026,
  author = {Gigante, Valeria and Murtagh, Maurine and Bachmann, Till T and Rocke, Tamarie and Trainor, Betsy W and Poutanen, Susan M and Roberts, Teri and Vila, Jordi and Cameron, Alexandra},
  title = {Diagnostics for priority bacterial pathogens: global gaps and research needs for curbing antimicrobial resistance in low-resource settings},
  journal = {The Lancet Microbe},
  year = {2026},
  volume = {7},
  number = {7},
  pages = {101385},
  doi = {10.1016/j.lanmic.2026.101385}
}
Kostenlos starten →